Home > Healthcare > Biotechnology > Biotechnology R&D > Whole Slide Imaging Market
The whole slide imaging industry is projected to show significant growth over the upcoming years due to the increasing drug discovery as pharmaceutical companies and research institutions recognize the value and potential of digital pathology. The adoption of whole slide imaging technology, along with advancements in artificial intelligence (AI) and image analysis, is likely to accelerate the drug discovery process, improve efficiency, and facilitate the development of new therapies. For instance, whole slide imaging enables the scanning and digitization of large numbers of tissue samples, allowing researchers to rapidly screen and analyse specimens. This capability is particularly valuable in drug discovery in which the screening of numerous potential drug candidates against tissue samples is essential.
Additionally, increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders, often require detailed examination of tissue samples to make accurate diagnosis and determine appropriate treatment options. Pathologists use microscopy techniques to analyse these samples, and whole slide imaging offers an advanced digital alternative to traditional microscopy.